[{"Assets_0_Q3_USD":1509576000.0,"CommonStockSharesOutstanding_0_Q3_shares":122889854.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-68089000.0,"NetIncomeLoss_1_Q3_USD":-45364000.0,"NetIncomeLoss_3_Q3_USD":-121175000.0,"StockholdersEquity_0_Q3_USD":716729000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":118291000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":311481000.0,"Ticker":"EXAS","CIK":"1124140","name":"EXACT SCIENCES CORP","OfficialName":"Exact Sciences Corporation Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"12010562930.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20181030"}]